Hepalink
Overview
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. provides pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. It operates in four segments: Pharmaceutical preparations, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization (CDMO), and Others. The company offers pharmaceutical preparations products, such as enoxaparin sodium injection; API products, including heparin and enoxaparin sodium APIs. It also provid
Employees2150
Market Cap$13.9B
Revenue$5.4B
Listed OnShenzhen Stock Exchange
Ticker002399
CEOMr. Li Li
HeadquartersShenzhen